2010

1. Effect of nateglinide on the incidence of diabetes and cardiovascular events

   New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1463-1476

2. Effect of valsartan on the incidence of diabetes and cardiovascular events

   New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1477-1490

3. Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis

   Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Núm. 7, pp. 3105-3110